## MCK: McKesson Corporation - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 1.1% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.1% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($786.34)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. Voya Investment Management LLC Increases Stake in McKesson Corporation $MCK**
- Source: MarketBeat | 20251219T140834 | Bullish | Relevance: 100%
- Voya Investment Management LLC increased its stake in McKesson Corporation by 11.9% in the third quarter, bringing its total holdings to 598,880 shares valued at approximately $462.1 million. The article also details other institutional investor activity, an insider stock sale by CAO Napoleon B. Rutledge, Jr., and recent analyst ratings. McKesson reported strong quarterly earnings and declared a quarterly dividend.

**2. Montecito Bank & Trust Buys Shares of 1,915 McKesson Corporation $MCK**
- Source: MarketBeat | 20251218T120631 | Bullish | Relevance: 100%
- Montecito Bank & Trust has initiated a new position in McKesson Corporation (NYSE:MCK) by purchasing 1,915 shares valued at approximately $1.48 million during the third quarter. Other institutional investors also adjusted their holdings in McKesson, with hedge funds and institutional investors collectively owning about 85.07% of the company's stock. McKesson recently reported strong quarterly earnings, surpassing EPS estimates, and declared a quarterly dividend of $0.82 per share.

**3. Thrivent Financial for Lutherans Has $11.76 Million Stock Holdings in McKesson Corporation $MCK**
- Source: MarketBeat | 20251218T104933 | Somewhat-Bullish | Relevance: 100%
- Thrivent Financial for Lutherans reduced its stake in McKesson Corporation by 13.4% during Q2, holding 16,117 shares valued at $11.76 million. Other institutional investors also adjusted their positions in MCK, with total institutional ownership standing at 85.07%. McKesson recently reported strong Q3 earnings, beating analyst estimates, and announced a quarterly dividend.

**4. Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of McKesson Corporation (NYSE:MCK)**
- Source: MarketBeat | 20251218T011249 | Bullish | Relevance: 100%
- Representative Gilbert Ray Cisneros, Jr. recently purchased between $1,001 and $15,000 worth of McKesson Corporation (NYSE:MCK) shares on November 18th, as disclosed on December 15th. McKesson reported strong Q3 earnings, exceeding EPS estimates and showing a 10.2% increase in revenue year-over-year, alongside announcing a quarterly dividend of $0.82 per share. The stock currently trades around $806.86, and analysts maintain a "Moderate Buy" consensus with an average target price of $892.86.

**5. Fortune 50 company sells shuttered Rock Hill facility for $26.5M**
- Source: The Business Journals | 20251217T195001 | Neutral | Relevance: 100%
- McKesson Medical-Surgical Inc. has sold its former Rock Hill facility for $26.5 million to an Atlanta-based investor. The medical supplies distributor had previously closed this warehouse earlier in the year, resulting in layoffs for nearly 180 workers. The report indicates a significant transaction involving a Fortune 50 company's divested asset.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Barclays | $960 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Barclays | init | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 1 ($0.28M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.8% (-0.3%)
- Blackrock Inc.: 9.2% (+0.4%)
- State Street Corpora: 4.7% (+0.9%)
- JPMORGAN CHASE & CO: 4.5% (+16.0%)
- Massachusetts Financ: 3.2% (-1.5%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-2.1% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.98 indicates undervaluation relative to growth. Balance sheet: $2.3B free cash flow. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $102.0B |
| Beta | 0.38 |
| 52W Range | $565.75 - $895.58 |
| Short Interest | 1.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.98 |
| Forward P/E | 18.7 |
| Current P/E | 21.2 |
| YoY Growth | 13.3% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 3.1% to 1.1% (-2.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.9pp (needs >3.0% for momentum thesis). MRS_5 (-0.4%) diverging from MRS_10 - short-term weakness emerging. Long-term uptrend intact (above SMA200 at 1.12x) but short-term weakness (below SMA20). MACD histogram bearish (-2.23), momentum weakening. RSI neutral at 49. OFD pattern: +SUH (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.05% (CS: 72) | Neutral |
| RSI_14 | 49.0 | Neutral |
| MACD Histogram | -2.23 | Bearish |
| vs SMA20 | 0.988x | Below |
| vs SMA50 | 0.996x | Below |
| vs SMA200 | 1.120x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $820.40
- **Stop Loss:** $786.34 (4.2% risk)
- **Target:** $854.46 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 35
- **Position Value:** $28,714.00
- **Portfolio %:** 28.71%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

**Next:** 2026-02-04 (Est: $9.28)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $9.05 | $9.86 | +8.9% |
| 2025Q2 | $8.15 | $8.26 | +1.4% |
| 2025Q1 | $9.83 | $10.12 | +3.0% |
| 2024Q4 | $7.99 | $8.03 | +0.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*